Analyze Diet

Topic:Immunology

The equine immune system is a complex network of cells, tissues, and organs that work collaboratively to defend against pathogens and maintain homeostasis. It consists of innate and adaptive components, each with distinct functions and mechanisms. The innate immune system provides the first line of defense through physical barriers, phagocytic cells, and the complement system. The adaptive immune system involves lymphocytes, such as B cells and T cells, which generate specific responses to antigens and provide immunological memory. Research in equine immunology explores the interactions between these components, the impact of genetic and environmental factors on immune function, and the development of vaccines and therapeutics. This page gathers peer-reviewed studies and scholarly articles focusing on the mechanisms, regulation, and clinical applications of the equine immune system in health and disease.
Analogies between Influenza of Horses and Influenza of Man.
Proceedings of the Royal Society of Medicine    January 1, 1924   Volume 17, Issue Sect Epidemiol State Med 47-58 
Williams AJ.No abstract available
STANDARDIZATION OF ANTIMENINGOCOCCIC SERUM.
The Journal of experimental medicine    November 30, 1918   Volume 28, Issue 6 779-790 doi: 10.1084/jem.28.6.779
Amoss HL, Marsh P.Experiments were made for the purpose of testing the reaction of protection against infection as a measure of potency of antimeningococcic serum. The results of the experiments were extremely variable and bore no relation to the quality of the sera as determined by the period of immunization of the horses from which they were obtained, or the indications of efficiency based upon their employment in human cases of epidemic meningitis. The results also failed entirely to conform to the agglutination titer of the sera tested and to be affected by the different type forms of the meningococci. We r...
A Note on the Production of Antipneumococcus Sera.
The Journal of experimental medicine    May 1, 1917   Volume 25, Issue 5 629-632 doi: 10.1084/jem.25.5.629
Wadsworth AB, Kirkbride MB.Horses immunized to Type I pneumococci developed serum, 0.1 cc. of which protected against 0.5 cc. of a virulent culture, 0.000001 cc. of which killed mice in less than 40 hours. Protective tests of serum from horses immunized to Type II organisms varied, 0.1 cc. protecting, however, in certain instances against 0.1 and 0.01 cc. of virulent homologous culture. Types I and II sera obtained in our experiments with culture sediment and whole culture did not vary markedly for a given type and corresponded closely in their protective titer with samples of sera received from The Rockefeller Institut...
PARAMENINGOCOCCUS AND ITS ANTISERUM.
The Journal of experimental medicine    September 1, 1914   Volume 20, Issue 3 201-217 doi: 10.1084/jem.20.3.201
Wollstein M.The parameningococci of Dopter are culturally indistinguishable from true or normal meningococci, but serologically they exhibit differences as regards agglutination, opsonization, and complement deviation. Because of the variations and irregularities of serum reactions existing among otherwise normal strains of meningococci it does not seem either possible or desirable to separate the parameningococci into a strictly definite class. It appears desirable to consider them as constituting a special strain among meningococci not, however, wholly consistent in itself. The distinctions in serum rea...
The Bacteriology and Vaccine Therapy of Distemper in Horses.
The Journal of experimental medicine    May 1, 1913   Volume 17, Issue 5 511-516 doi: 10.1084/jem.17.5.511
Lintz W.This research article focuses on the study of distemper, also known as influenza or shipping fever, in horses, specifically focusing on its bacteriology and potential vaccine therapies. The research was […]
Active Immunity Produced by So-Called Balanced or Neutral Mixtures of Diphtheria Toxin and Antitoxin.
The Journal of experimental medicine    March 1, 1909   Volume 11, Issue 2 241-256 doi: 10.1084/jem.11.2.241
Smith T.The foregoing and earlier data taken together demonstrate that an active immunity lasting several years can be produced in guinea-pigs, by the injection of toxin-antitoxin mixtures which have no recognizable harmful effect either immediate or remote. They also show, what might have been anticipated, that under the same conditions mixtures which produce local lesions and which, therefore, contain an excess of toxin produce a much higher degree of immunity than the neutral mixtures, and that an excess of antitoxin reduces the possibility of producing an active immunity, and may extinguish it alt...
Comparative Statistics of Antitoxin Horses: A Study of the Records of One Hundred Horses Immunized to Diphtheria Toxin, with Composite of Curves.
The Journal of experimental medicine    April 25, 1905   Volume 7, Issue 2 176-182 doi: 10.1084/jem.7.2.176
Hubbert WR.1. Better results in the production of diphtheria antitoxin can be obtained with greater experience in the selection of the most suitable type of horses to be used. Young animals are usually to be preferred. Over one-half of all such horses can be made to yield 300-unit serum, while a third will yield (5)oo-unit serum. 2. High-test horses require a shorter time to immunize and will yield a potent serum for a longer period than will low-test horses. 3. The period of usefulness of an antitoxin horse is short, and on an average endures only a few months. 4. A horse having attained a maximal antit...
The Period of development, the time of greatest Accumulation, and the Persistance of Diphtheria Antitoxin in the Blood of a Series of One Hundred Horses.
The Journal of medical research    March 1, 1903   Volume 9, Issue 2 173-179 
Atkinson JP.No abstract available
The Fractional Precipitation of the Globulin and Albumin of Normal Horse’s Serum and Diphtheria Antitoxic Serum, and the Antitoxic Strength of the Precipitates.
The Journal of experimental medicine    October 1, 1900   Volume 5, Issue 1 67-76 doi: 10.1084/jem.5.1.67
Atkinson JP.1. The globulins of both normal and diphtheria antitoxic serum exhibit chemically toward reagents the same reactions, being precipitated by magnesium sulphate and split up into fractions in precisely the same way. 2. All of the diphtheric antitoxic power of both normal and immunized serum is always carried by the globulin and its fractional precipitates. 3. During the fractional precipitation of the serum globulin of horses immunized from diphtheria toxin and horses not immunized from diphtheria toxin, some of the globulin is lost, likewise at the same time some of the antitoxic power of the g...
Epizootic Cellulitis among Horses.
The Journal of comparative medicine and veterinary archives    August 1, 1899   Volume 20, Issue 8 511-512 
Manley .No abstract available
Diphtheria Antitoxin Sometimes Found in the Blood of Horses That Have Not Been Injected with Toxin.
The Journal of experimental medicine    July 1, 1896   Volume 1, Issue 3 543-545 doi: 10.1084/jem.1.3.543
Bolton BM.No abstract available
Abstract of the Investigations Thus Far Made in the Use of Equine Scarlatinal Virus.
The Journal of comparative medicine and surgery    April 1, 1884   Volume 5, Issue 2 145-149 
Stickler JW.No abstract available
Indochoroiditis-Periodic Ophthalmia in Horses.
The Journal of comparative medicine and surgery    July 1, 1883   Volume 4, Issue 3 234-235 
Moore WO.No abstract available
Equine Herpesvirus-1 Myeloencephalopathy.
   March 15, 2026  
Although equine herpesvirus myeloencephalopathy (EHM) is a relatively uncommon manifestation of equine herpesvirus-1 (EHV-1) infection, it can cause devastating losses during outbreaks. Antemortem diagnosis of EHM relies mainly on the molecular detection of EHV-1 in nasal secretions and blood. Management of horses affected by EHM is aimed at supportive nursing and nutritional care, at reducing central nervous system inflammation and preventing thromboembolic sequelae. Horses exhibiting sudden and severe neurologic signs consistent with a diagnosis of EHM pose a definite risk to the surrounding...
Hunting for a key to the enigma of heaves in the black box of the white cells.
   March 15, 2026  
No abstract available
Research article expression of surfactant protein-A and D, and CD9 in lungs of 1 and 30 day old foals.
   March 15, 2026  
Respiratory diseases are a major cause of morbidity and mortality in the horses of all ages including foals. There is limited understanding of the expression of immune molecules such as tetraspanins and surfactant proteins (SP) and the regulation of the immune responses in the lungs of the foals. Therefore, the expression of CD9, SP-A and SP-D in foal lungs was examined. Results: Lungs from one day old (n = 6) and 30 days old (n = 5) foals were examined for the expression of CD9, SP-A, and SP-D with immunohistology and Western blots. Western blot data showed significant increase in the...
Equine arteritis virus.
   March 15, 2026  
Equine arteritis virus (EAV) is the causative agent of equine viral arteritis (EVA), a respiratory and reproductive disease of equids. There has been significant recent progress in understanding the molecular biology of EAV and the pathogenesis of its infection in horses. In particular, the use of contemporary genomic techniques, along with the development and reverse genetic manipulation of infectious cDNA clones of several strains of EAV, has generated significant novel information regarding the basic molecular biology of the virus. Therefore, the objective of this review is to summarize cur...
Complement factor B expression profile in a spontaneous uveitis model.
   March 15, 2026  
Equine recurrent uveitis serves as a spontaneous model for human autoimmune uveitis. Unpredictable relapses and ongoing inflammation in the eyes of diseased horses as well as in humans lead to destruction of the retina and finally result in blindness. However, the molecular mechanisms leading to inflammation and retinal degeneration are not well understood. An initial screening for differentially regulated proteins in sera of uveitic cases compared to healthy controls revealed an increase of the alternative pathway complement component factor B in ERU cases. To determine the activation status ...
1 181 182 183